The Knowledge Hub for Medical Imaging Professionals: Transforming Radiology with Structured Reporting, Data-Driven Approaches and Multicentric Research

Access breakthrough research, innovative case studies and collaborative projects advancing radiology worldwide. Dive into our activities and product updates, and learn who we are as a company and as a team.

Connected logos of AGFA Healthcare and Mint Medical to signify seamless integration of both systems

Seamless Integration of mint Lesion and ORBIS RIS – Presented at RSNA 2018

Radiology reporting is becoming increasingly complex – while users expect simple, seamless workflows. This is exactly where the new integration of mint Lesion and ORBIS RIS, presented at RSNA 2018, comes into play.

This integration is a major improvement of the interaction of both systems for joint customers, especially for the use in clinical routine. Users are now able to open mint Lesion directly from the ORBIS RIS reporting within the same patient and user context. After completion of the reading and reporting in mint Lesion, the results are automatically integrated into the ORBIS RIS report.

A Win for Users and Patient Care

"An efficient radiological assessment, with the assistance of modern IT systems, is crucial for user satisfaction. The better involved systems interact, the more comfortable the user experience, and we are pleased to be able to offer this to our customers,” states Dr. Matthias Baumhauer, CEO, Mint Medical GmbH.

Agfa HealthCare also highlights the importance of this step. Winfried Post, General Manager and Managing Director, Agfa HealthCare DACH, explains:

"With the integration of mint Lesion with ORBIS RIS we respond to the great wish of our joint customers for a convincing interaction of both systems. We are convinced that the future belongs to those systems that open up and, in the interest of our customers, can be well integrated into each other.”

Existing as well as new customers can order the integration solution directly from Mint Medical, and its implementation is realized in close coordination with the Agfa HealthCare team.

More than Technology

mint Lesion allows for multi-modality reading and reporting while at the same time considering the concrete reading task as well as the relevant guideline and automatically creates a structured report. The software guides the user through the reading process ensuring all relevant pieces of information are captured and are therefore conform with e.g. the ACR RADS classification, the TNM criteria or therapy response criteria like RECIST 1.1.

ORBIS RIS is one of the leading RIS in the German-speaking countries and is used by more than 400 customers.

Learn more about mint Lesion. Contact us here.

About Agfa HealthCare:

Agfa HealthCare is a leading provider of IT-based healthcare solutions for the use in hospitals and healthcare institutions all over the world. Furthermore, Agfa HealthCare is one of the leading providers of healthcare information systems for the integration of clinical, administrative and financially relevant workflows of single hospitals and hospital groups.

Related Resources

Related Resources

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…